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Abstract
Background: Celiac Disease (CD) is an autoimmune disorder of the small intestine in which dietary gluten ingestion 
leads to a chronic enteropathy. Recently, scientific evidence suggested a potential role of gut microbiota in CD. To have 
a snapshot of dominant duodenal microbiota we analyzed the mucosa-associated microbiota of 20 children with CD, 
before and after a gluten-free diet (GFD) regimen, and of 10 controls. Total DNA was extracted from duodenal biopsies 
and amplification products of 16S ribosomal DNA were compared by temporal temperature gradient gel 
electrophoresis (TTGE). TTGE profiles were analyzed by statistical multivariate analysis.
Results: The average number of bands in TTGE profiles was significantly higher (P < 0.0001) in active (n.b. 16.7 ± 0.7) 
and inactive states (n.b. 13.2 ± 0.8) than in controls (n.b. 3.7 ± 1.3). Mean interindividual similarity index was 54.9% ± 
14.9% for active disease, 55.6% ± 15.7% for remission state and 21.8% ± 30.16% for controls. Similarity index between 
celiac children before and after GFD treatment was 63.9% ± 15.8%. Differences in microbiota biodiversity were among 
active and remission state (P = 0.000224) and amid active CD and controls (P < 0.001). Bacteroides vulgatus and 
Escherichia coli were detected more often in CD patients than in controls (P < 0.0001).
Conclusions: Overall, the results highlighted a peculiar microbial TTGE profile and a significant higher biodiversity in 
CD pediatric patients' duodenal mucosa. The possible pathophysiological role of these microbial differences needs 
further characterization.
Background
Celiac disease (CD) is an immune-mediated enteropathy
triggered by the ingestion of gluten-containing grains
(including wheat, rye, and barley) in genetically suscepti-
ble individuals [1]. Its estimated prevalence in Western
Countries is near 1% [2]. It is generally agreed that CD is a
T-cell mediated disorder in which gliadin derived pep-
tides activate lamina propria T lymphocytes which
release proinflammatory cytokines [3]. To date, several
peptides including alpha- and gamma-gliadins, have been
reported to activate CD4+ lymphocytes via their interac-
tion with HLA-DQ2 and -DQ8 heterodimer on antigen
presenting cells (APC) [4].
Recently, scientific evidence showed microecological
changes in the intestinal tract of celiac infants, suggesting
a potential role of gut microbiota in CD. Alterations in
the composition of faecal short-chain fatty acids in CD
patients compared with those of healthy controls have
been demonstrated [5]. Imbalance in the composition of
duodenal microbiota or in faecal bacterial communities
of children with CD has also been reported [6-9]. Rod-
shaped bacteria have been observed in both gluten-free
diet (GFD)-treated and untreated pediatric
patients'mucosa, along with a distinctive lectin pattern
[10].
The present study was carried out to add further infor-
mation on the characterization of intestinal microbiota of
CD patients, a variable that may represent a new piece of
the intriguing puzzle of CD illness. For this purpose we
analyzed by TTGE the composition of duodenal mucosa-
a s s o c i a t e d  m i c r o b i o t a  i n  t h e  s a m e  c o h o r t  o f  G F D
untreated and treated CD children and in controls. This
prospective study was performed to compare the influ-
ence of the disease status on gut microbial composition
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and to study whether the microbial imbalance could be a
peculiar characteristic of the disease.
Results
Agglomerative hierarchical classification (AHC)
The TTGE profiles of PCR amplicons obtained with uni-
versal primers were firstly analyzed by XLStat software.
The resulting dendrogram presented two major well-
defined clusters (fig 1). The first cluster (A) groups 8/10
of control patients, while the second one (B) groups 18/20
of CD patients (Chi-square = 26.51, P < 0.005, DF = 1;
Fisher's test P = 3,46 × 10-6). These results highlighted the
presence of a dominant microbiota related to the celiac
disease, irrespectively to the disease status. The average
number of bands in TTGE profiles, calculated by Digi-
Doc-It software, was significantly higher (P < 0.0001) in
celiac children (active n.b. 16.7 ± 0.7, inactive n.b. 13.2 ±
0.8) than in controls (n.b. 3.7 ± 1.3), indicating that duo-
denal mucosa of CD patients showed a higher diversity of
associated bacterial population. The average number of
bands in TTGE profiles was also significantly higher in
active disease than inactive one (P = 0.0012). Moreover,
interindividual analysis showed a mean Dice similarity
index of TTGE profiles of 54.9% ± 14.9% within active
disease group, 55.6% ± 15.7% within inactive disease
group and 21.8% ± 30.16% within control group. Other-
wise, mean Dice similarity index between celiac individu-
als before and after GFD treatment was 63.9% ± 15.8%.
Ecological features
Shannon-Wiener index (H') analysis was performed to
determine a measure of estimated diversity within each
biopsy sample by TTGE profiles. Mean Shannon-Wiener
index value differed significantly between active (A) and
inactive (I) CD patients, a similar result was obtained
between active CD patients and controls. The Shannon-
Wiener index among inactive CD patients and controls
was not significantly different. (fig 2). The variance values
(V) relative to active group revealed a minor data disper-
sion than inactive and control ones, indicating a more
similar microbial biodiversity between its members (fig
2). The carrying capacity of the duodenal system showed
Figure 1 TTGE profiles dendogram. TTGE of 16S rDNA amplicons of the bacterial community adherent to duodenal mucosa biopsy samples taken 
from 20 CD patients who were studied during both active (a) and inactive (i) celiac disease, and 10 controls (c). The dendogram gives a statistically 
optimal representation of similarities between TTGE profiles based on Euclidean distance dissimilarity matrix and agglomeration method of Ward. The 
threshold was set at 35% of dissimilarity. Bands of TTGE marker (M) are numbered as follows: 1,6, Bacteroides vulgatus; 2,3,7, Parabacteroides distasonis; 
4, Bacteroides thetaiotaomicron; 5, Escherichia coli.Schippa et al. BMC Microbiology 2010, 10:175
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mean Rr values of: 256.7 ± 98.5, 153.3 ± 64.5, 19.2 ± 41.1
for active, inactive and control group respectively. The
mean  Rr  values were highly different among the three
groups (p < 0.001).
Factor discriminating analysis (FDA)
To improve the analysis of TTGE profiles the more dis-
criminating FDA approach was performed. The Principal
Component Analysis (PCA) transformed data showed a
well-defined separation between controls, active and
inactive celiac groups (Lambda = 0.0012, P  = 0.0044),
with a confusion matrix of 0.0% (fig 3). Results from this
analysis indicated that the TTGE profiles were sufficient
to predict the patient category (active CD, inactive CD or
non CD patient) with 100% predictiveness, suggesting the
importance of duodenal microbiota in this pathology.
Partial least square discriminant analysis (PLS-DA)
PLS-DA was employed to investigate peculiar TTGE
bands having discriminatory power in separating TTGE
profiles in the three groups studied, utilizing the raw data
(fig 4). The score plot confirmed a division between the
patients' groups. Interestingly, in patients n. 12 and 19 the
TTGE profiles of inactive status resulted closer to those
of control group. On the basis of PLS-DA score plot, it
could be seen that CD patients and controls were sepa-
rated along Principal Component 1 (PC1) component,
w h i l s t  a c t i v e  a n d  i n a c t i v e  C D  p a t i e n t s  w e r e  s e p a r a t e d
along Principal Component 2 (PC2) component. Fig 5
shows hierarchical discriminatory importance of the
TTGE bands for PC1 component and PC2 component.
The variable importance (VIP) mainly reflected the cor-
relation between the TTGE bands and all the patients
groups along a specific principal component axis (PC1
and PC2). The bands with VIP larger than 1 were picked.
Figure 3 TTGE profiles FDA model. Factorial discriminant analysis 
(FDA) plot for TTGE profiles from CD patients studied, during both ac-
tive () and inactive () celiac disease, and controls (). The percent-
ages of variation described by the factorial axes (F1,F2) are shown in 
the parentheses. Center of gravity for each group is reported as filled 
symbol. Mahalanobis distances (D2), between the three centers of 
gravity were: active vs inactive = 93.030; active vs control = 551.840; in-
active vs control = 290.021. Comparison of the aforementioned dis-
tances was statistically significant (Mann-Whitney and Wilcoxon tests, 
P < 0.0001) between the three groups of patients. The predictability of 
the model is 100%.
Figure 4 TTGE profiles PLS-DA model. PLS-DA score plot of TTGE 
bands profiles from CD patients, during both active and inactive celiac 
disease, and controls. In brackets are the percentages of total variation 
of the dataset explained by the first two components PC1 and PC2. The 
major ellipse represents Hotelling's T2 range at 95% confidence for the 
entire dataset (T2dataset = 6.51), whilst minor ellipses represent Hotell-
ing's T2 range at 95% confidence for every single group (T2active = 2.45, 
T2inactive = 1.88, T2control = 1.52). The predictability of PLS-DA model was 
88%, with a Fisher's test P value of 5.3*10-8.
Figure 2 Duodenal microbial community biodiversity. Measure of 
estimated diversity within each biopsy sample obtained from TTGE 
profiles of CD patients studied during both active (A) and inactive (I) 
celiac disease, and controls (C). For each group, the diversity index (H'), 
according to Shannon-Weaver and the intra-group variance (V), are 
shown. The mathematical equation to calculate diversity index for 
each TTGE profile was with Pi = ni/Ntot, that takes in account the num-
bers of bands (s), their relative intensity (ni) and sum (Ntot). P values for 
each inter-group comparison are showed.Schippa et al. BMC Microbiology 2010, 10:175
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The TTGE bands picked partitioning CD and non CD-
diagnosed patients were: 26, 18, 39, 35, 1, 13, 15, 29, 3, 6,
22, 16. The picked TTGE bands separating active and
inactive CD patients were: 8, 1, 6, 7, 21, 26, 39, 13, 18, 35,
12, 15, 5, 29, 19, 9.
Statistical evaluation of TTGE bands occurrence by PLS-DA
The selected TTGE bands obtained by PLS-DA analysis
were statistically evaluated for their occurrence as
reported in table 1. The TTGE selected bands (VIP > 1)
dividing CD and controls resulted all statistically signifi-
cant (P < 0.05). In the separation between active and inac-
tive CD patients, bands resulted statistically significant
were: 8, 1, 7, 21, 18 and 12. Moreover, some of selected
TTGE bands run parallel with E. coli, P. distasonis and B.
vulgatus gel markers used. The parallelism is reported in
Tab. 2.
Species-specific PCR
Results obtained revealed a highly significant difference
(P < 0.001) in the prevalence of B. vulgatus (85% vs. 20%),
and E. coli (95% vs. 20%) in CD patients versus controls.
A significant difference (P < 0.047) was found in the prev-
alence of B. vulgatus (80% vs. 90%) and in the prevalence
(P = 0.039) of Clostridium coccoides group (50% vs. 90%)
in active CD patients versus inactive CD one. No signifi-
cant difference was found in the prevalence of Bifidobac-
terium spp. between CD patients and controls (30% vs.
Figure 5 TTGE band importance. Hierarchical variable importance (VIP) of discriminatory TTGE bands for PC1 component (partitioning CD/non CD 
patients, upper panel) and PC2 component (partitioning active CD/in remission CD patients, lower panel). * P < 0.05, **P < 0.01.Schippa et al. BMC Microbiology 2010, 10:175
http://www.biomedcentral.com/1471-2180/10/175
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Table 1: Statistical importance of discriminating TTGE bands
CD patients vs Controls (PC1)
TTGE band § Active + Inactive (%) Control (%) VIP P value (a)
26 (E.coli) 92.1 20.0 2.023 < 0.0001
18 (P.distasonis) 86.8 20.0 1.867 < 0.0001
39 (P.distasonis) 89.5 20.0 1.847 0.0001
35 73.7 0.0 1.802 < 0.0001
1 (B.vulgatus) 89.5 20.0 1.755 0.001
13 57.9 0.0 1.580 0.000
15 63.2 0.0 1.535 0.001
29 60.5 0.0 1.516 0.001
3 52.6 0.0 1.311 0.003
6 60.5 0.0 1.194 0.010
22 52.6 10.0 1.151 0.007
16 39.5 0.0 1.024 0.018
Active CD patients vs Inactive CD patients (PC2)
TTGE band§ Active(%) Inactive(%) VIP P value(b)
8 (P.distasonis) 31.6 0.0 1.691 0.009
1 (B.vulgatus) 84.2 94.7 1.687 0.026
6 47.4 73.7 1.667 0.089
7 26.3 0.0 1.522 0.015
21 21.1 0.0 1.507 0.023
26 94.7 89.5 1.498 0.474
39 89.5 89.5 1.475 1.000
13 73.7 42.1 1.316 0.054
18 94.7 78.9 1.299 0.032Schippa et al. BMC Microbiology 2010, 10:175
http://www.biomedcentral.com/1471-2180/10/175
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20%, P = 0.742) and between active and inactive CD (20%
vs. 40%, P = 0.302).
Discussion
This is the first longitudinal study on the duodenal
mucosa-associated microbiota, carried out on the same
cohort of CD pediatric patients (in active and in remis-
sion disease), showing a distinctive 'microbial structure'
in celiac pediatric patients. The most important results of
this study, obtained through multivariate statistical analy-
sis of TTGE profiles, were: i) a dominant duodenal micro-
biota that could be linked to the disease status (active and
remission), outlining differences in the microbiota com-
position before and after GFD treatment; ii) a signifi-
cantly higher diversity in dominant microbiota in patients
with active disease vs the same in remission state, as well
as in patients with active disease vs controls, as revealed
by Shannon-Wiener index. This higher duodenal micro-
bial diversity in CD patients could have a possible harm-
ful impact on the duodenal homeostasis. iii) a higher
inter-individual similarity in CD patients than controls,
indicating a more homogeneous structure among micro-
bial communities of celiac patients.
Analyzing TTGE profiles, the lowest carrying capacity
and the lowest median number of bands found in the
duodenal system of the control group can be attributed to
an environment particularly adverse or restricted to colo-
nization. The nature of duodenal habitat is radically
changed in CD patients, where the carrying capacity and
the median number of bands in TTGE profiles are much
higher than controls, consequently a thriving coloniza-
tion could be due to a more habitable environment. It
could be speculated that in duodenum the microbial life
could be largely inhibited by different factors such the
rapid transit of food (transit time 2.5 hours compared to 5
hours of stomach), pancreatic juices or the rapid mucosal
turnover. Is therefore likely that a relative small number
of definite microbial species or groups are highly adapted
to this particular habitat, then the number of TTGE
bands found in our control duodenal samples was lower
than others found in different intestinal tracts [11,12].
The Dice index analysis of TTGE profiles revealed that
mucosa-associated microbiota differed markedly from
one patient to another in control group, whereas CD
patients showed a high inter-individual similarity. More-
over, before and after GFD treatment, there's a loss of
36.1% of inter-individual similarity. Specifically, the simi-
larity is lost in a homogeneous way between all celiac
individuals, as showed by the high similarity Dice index
within active and inactive groups. We may speculate that
the change in the mucosa lectin patterns both in active
and remissive CD, as demonstrated by Forsberg [9], could
create more selective microbial adhesive patterns in duo-
denal mucosa of these patients, promoting a more similar
interindividual mucosal colonization.
TTGE bands, having discriminatory power in separat-
ing the three patients'groups, have been selected. Some of
these TTGE bands run parallel with E. coli, P. distasonis
and B. vulgatus gel markers used. The genera Bacteroides,
as reported by previous works [8,7], was significantly
increased providing a strong correlation between this
microbial group and CD [8,6]. Moreover a high preva-
lence of potentially pro-inflammatory gram negative bac-
teria was found in the celiac patients' duodenum [6].
35 78.9 68.4 1.271 0.255
12 36.8 10.5 1.258 0.049
15 68.4 57.9 1.079 0.386
5 36.8 15.8 1.056 0.083
29 68.4 52.6 1.054 0.237
19 47.4 63.2 1.046 0.237
9 78.9 94.7 1.031 0.255
§ Bands were self numbered according to the order of appearance (top-bottom) on the TTGE gel and are listed in descending order of importance 
(VIP) in the PLS-DA model. Between parentheses are reported the species used in the gel marker that run parallel to specific TTGE bands.
(a) Mann-Whitney U-test, α = 0.05
(b) Wilcoxon signed rank test, α = 0.05
Table 1: Statistical importance of discriminating TTGE bands (Continued)Schippa et al. BMC Microbiology 2010, 10:175
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Furthermore, the presence of bacteria such E. coli and
Bacteroides spp has been related by other authors [13,14]
with mucin degradation and an increase in small intesti-
nal permeability. Although the technique we used does
not allow a specific characterization of microbial species
or groups of this particular intestinal habitat, it provides a
picture of modifications encountered by dominant bacte-
rial groups/species profile of a sample in relation to dif-
ferent factors (i.e. disease status). The presence/absence
of bacterial species/groups might act as 'key' or 'regula-
tory' species leading to a different relative abundance of
the present species. To assess this, we need to improve
o u r  d a t a  b y  d i r e c t  s e q u e n c i n g  o f  T T G E  b a n d s.  T T G E
profiles of 18/20 CD patients in remission, with a duode-
nal histology not fully normalized, clustered together and
away from controls. Interestingly, TTGE profiles of 2 CD
patients (12 and 19) with a fully histological duodenal
normalization at GFD, clustered close to controls as
reported by the PLS-DA score plot. This would indicate
an association between inflammatory status of intestinal
mucosa and the kind of colonizing microbiota. Partial
recovery of microbiota composition in the 2 patients with
full histological normalization seems to indicate that the
mucosa inflammation status is not the only factor driving
the kind of microbial composition, but certainly is an
influencing factor.
Conclusions
In conclusion, our data show a potential role of the duo-
denal microbiota in the CD pathogenesis. Common
TTGE profiles in CD patients are probably due to a simi-
lar intestinal habitat creating selective pressures that
shape a peculiar dominant microbiota. In addition, the
occurrence of distinctive TTGE profiles in celiac patients
before and after GFD treatment could open new thera-
peutic strategies aimed at restoring the intestinal ecosys-
tem balance. Further studies will be necessary to develop
such strategies, as well as a more accurate identification
of bacterial species or groups having discriminatory
properties in the CD spectrum.
Methods
Patients
Two groups of children referred to the Pediatric Gastro-
enterology and Liver Unit of the "Sapienza" University of
Rome were included in this study: 20 CD (mean age 8.3
years, range 1.2-16.1 years) in active and in remission
state (at diagnosis and after at least 9 months of gluten-
free diet, respectively) and 10 controls undergoing upper
gastrointestinal endoscopy for functional dyspepsia
(mean age 11.7 years, range 7.8-20.8 years). The latter
tested negative for antitransglutaminase and antien-
domysial antibodies with normal IgA levels, while histol-
ogy of duodenum did not reveal features of CD. Diagnosis
of CD had been performed according to ESPGHAN crite-
ria [15]. Table 2 summarizes clinical features of the stud-
ied population.
Size appropriate and well oriented endoscopic biopsy
specimens were obtained from the second part of the
duodenum. The histopathological diagnosis was based on
typical mucosal lesions with crypt cell hyperplasia, villous
atrophy, and increased number of intra-epithelial lym-
phocytes (IELs) [16]. All untreated CD patients were pos-
itive for antiendomysial and antitransglutaminase
antibodies at the time of diagnosis. In all patients there
was an endoscopic improvement of duodenal mucosa fol-
lowing gluten withdrawal, but only in 2 of them (patients
number 12 and 19) there was also a full histological
improvement. None of the children included in the study
was treated with antibiotics for at least 3 months before
the sampling time. The study protocol was approved by
the Committee on Ethical Practice of the 'Policlinico
Umberto I' hospital. Children were enrolled in the study
after written informed consent from their parents. The
biopsy samples were placed in liquid nitrogen immedi-
ately after their emission and stored at -80°C until analy-
sis.
Bacterial strains
The strains listed below were obtained from the Ameri-
can Type Culture Collection (ATCC) and used as marker
Table 2: Clinical data of patients' groups
Celiac Disease Controls
No. of cases (a) 20 10
Sex ratio (M/F) 8/12 3/7
Age at 1st biopsy(b)
(years; median and ranges)
8.3 (1.2-16.1) 11.7 (7.8-20.8)
Weight at birth (Kg) (mean ± 
SD)
3.3 ± 0.5 3.3 ± 0.4
GFD duration
(months; median and ranges)
9 (8-14) -
Marsh
IIIA 7/20 -
IIIB 6/20 -
IIIC 7/20 -
(a) None of the patients underwent previous endoscopic assessment
(b) Biopsies were taken in the second part of duodenumSchippa et al. BMC Microbiology 2010, 10:175
http://www.biomedcentral.com/1471-2180/10/175
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on TTGE gel electrophoresis: Bacteroides fragilis ATCC
23745, Bacteroides thetaiotaomicron ATCC 29148, Bacte-
roides vulgatus ATCC 8482, Parabacteroides distasonis
ATCC 8503, Escherichia coli MG1655. Bacterial DNA
was extracted with UltraClean kit (MO BIO Laboratories,
Solana Beach, California, USA) according to the manu-
facturer's instructions.
DNA extraction
Duodenal biopsy specimens from CD and control
patients were first quickly washed in 500 μL of physio-
logic saline with 0.016% dithiothreitol to remove luminal
bacteria from the mucus, and then utilized for DNA
extraction procedure by DNeasy tissue kit (Qiagen,
Hilden, Germany) according to the manufacturer's
instructions. In order to obtain maximum yield of both
Gram-positive and Gram-negative bacteria, a special step
in DNA purification protocol was added, following
DNeasy tissue kit manual. Briefly, 180 μL of ATL buffer
were added to sample followed by 180 μL volume of enzy-
matic lysis buffer (20 mM Tris·Cl, pH 8.0, 2 mM sodium
EDTA, 1.2% Triton® X-100, lysozyme to 20 mg/ml), and
incubated for 30 minutes at 37°C. Next, 25 μL of protei-
nase K solution and 200 μL of buffer AL were added, fol-
lowed by an incubation step at 56°C for 30 minutes.
DNA concentration was determined using an Eppen-
dorf biophotometer at 260 nm.
We obtained similar DNA concentrations after kit
extraction both from celiac patients and controls biop-
sies. A Mann-Whitney U test was performed on total
DNA concentration (P = 0.11), indicating a similar
amount of extracted DNA in both celiac and controls.
PCR amplification
Polymerase chain reaction (PCR) was performed, as pre-
viously described [17] using 400 ng of metagenomic
D N A ,  w i t h  m i n o r  m o d i f i c a t i o n .  B r i e f l y ,  t o  r u l e  o u t
unspecific PCR products we performed touchdown PCR
with a starting annealing temperature of 58°C and
decreasing it by 0.5°C each cycle to reach 53°C, then 30
cycles at 53°C were achieved. Same amounts of amplified
DNA were also obtained. A Mann-Whitney U test was
performed on PCR amplicons (P = 0.23), indicating a
similar amount of PCR products in both celiac and con-
trols. To minimize heteroduplex formation and single-
stranded DNA (ssDNA) contamination during PCR
amplification that might cause sequence heterogeneity in
a single TTGE band, an additional 5 cycles of recondi-
tioning PCR was performed, taking 1/10 of the previous
PCR volume as template in a new reaction. Moreover, we
used 16S rDNA V6-V8 region instead of V3-V4 region
that showed coamplification with human DNA. To avoid
the problem due to the low bacterial load we performed
six individual PCR reactions for each sample. The indi-
vidual PCR reactions were unified, analyzed by electro-
phoresis on 2% agarose gels containing ethidium bromide
to determine their size (498 bp), and concentrated with
SpeedVack (Savant, Holbrook, NY, USA). The unified
PCR reactions, before and after the concentration step,
were titrated using two different methods: first, densi-
tometry analysis of agarose gel by GelQuest software
(Sequentix, Klein Raden, Germany); second, measure of
DNA density by biophotometer at 260 nm. The results
obtained by such measures were in agreement each other.
PCR protocol was optimized to obtain maximum yield
from starting total DNA. The band intensity was quanti-
fied at every step (touchdown PCR, reconditioning PCR,
concentrated PCR) to ensure an equal DNA concentra-
tion. A first-step assessment of DNA suitability for subse-
quent PCR was achieved through a β-globin gene
amplification for each starting sample. Briefly, aliquots of
each DNA sample (50 ng) were amplified with specific
primers: forward primer, 5'-CAACTTCATCCACGT-
TCACC-3; reverse primer, 5'-GAAGAGCCAAGGA-
CAGGTAC-3'. Amplification reactions were carried out
in a 50-μl volume containing 1× PCR buffer II (Applied
Biosystems, Roche, California, USA), 3 mM magnesium
chloride, 200 μM each deoxynucleoside triphosphate, 50
pmol each primer and 5 Uμ/l AmpliTaq Gold polymerase
(Applied Biosystems). The PCR was carried out under the
following conditions: 1 cycle of 95°C for 7 min, 35 cycles
of 94°C for 1 min, 55°C for 1 min and 72°C for 1 min and 1
cycle of 72°C for 7 min. 500 ng of DNA of PCR product
from each sample were used to perform the subsequent
TTGE experiments.
TTGE analysis of PCR amplicons
We used the DCode Universal mutation detection system
(Bio-Rad, Paris, France) for the sequence-specific separa-
tion of PCR products. Electrophoresis was performed as
previously described [17]. TTGE runs were conducted in
triplicate and gel photographed with DigiDoc-It system
(UVP, Cambridge, UK).
Species-specific PCR
We choose to detect those particular species whose pres-
ence seems to be involved in celiac disease [7,9]. 16S
rDNA gene-targeted primers were utilized to detect
them. The primers used were ECO-1 5'-gacctcggtttagt-
tcacaga-3', ECO-2 5'-cacacgctgacgctgacca-3' for Escheri-
chia coli (585 bp); BV-1 5'-gcatcatgagtccgcatgttc-3', BV-2
5'-tccatacccgactttattcctt-3' for Bacteroides vulgatus (287
bp); g-Ccoc-F 5'-aaatgacggtacctgactaa-3', g-Ccoc-R 5'-
ctttgagtttcattcttgcgaa-3' for Clostridium coccoides group
(438-441 bp), g-Bifid-F 5'-ctcctggaaacgggtgg-3', g-bifid-R
5'-ggtgttcttcccgatatctaca-3' for Bifidobacterium spp (549-
563 bp). The PCR were performed as previously
described [18].Schippa et al. BMC Microbiology 2010, 10:175
http://www.biomedcentral.com/1471-2180/10/175
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Data Analysis
Agglomerative Hierarchical Classification (AHC.) Den-
drogram generated with XLStat 7.5 (Addinsoft, NY, USA)
on binary matrix of TTGE variables was evaluated by
one-tailed chi-squared test. Data were automatically
mean centred and unit variance (UV) scaled. A P value
equal or less 0.05 was considered statistically significant.
Dice similarity index (SD, mean % ± SD) was calculated
within the respective HC and CD groups to assess inter-
individual similarity by the formula SD = (2nAB)/(nA +
nB), where nA is the total number of bands in pattern A,
nB is the total number of bands in pattern B and nAB is the
number of bands common to pattern A and B. Ecological
features. Doc-It LS software (UVP, Cambridge, UK) was
used for TTGE bands densitometry peak height quantifi-
cation, and the correspondent data were analyzed for the
microbial biodiversity by Shannon-Wiener index with
SigmaPlot 9.0 software. Intra-group variance value (V
value) was also calculated. V value defines the variance of
data points in each cohort, representing the data disper-
sion, and indicating the homogeneity/heterogeneity
between individuals within a population. In addition, the
range-weighted richness (Rr), reflecting the carrying
capacity of the duodenal system, was calculated by the
formula  Rr  = N2 XTg, where N is the total number of
bands in the TTGE profile and Tg the temperature gradi-
ent comprised between the first and the last band of the
same pattern [19]. Principal Component Analysis (PCA).
Linearly-dependent TTGE variables were ortogonalized
in new factorial axes (F1,F2...Fn) through PCA by XLStat
7.5 (Addinsoft). The coordinates of the observations on
the factorial axes were considered new variables for sub-
sequent factorial discriminant analysis (FDA). Factor Dis-
criminant Analysis (FDA). FDA included in XLStat 7.5
software was performed to create a predictive model use-
ful to classify the patients into one of the three groups
according to their TTGE profile. Wilk's Lambda test was
used and a P value less than or equal to 0.05 was consid-
ered statistically significant. Partial Least Square Dis-
criminant Analysis (PLS-DA). PLS-DA included in
SIMCA+ software (UMETRICS, Umea, Sweden) was per-
formed to depict score plot of TTGE profiles by means of
principal components PC1 and PC2, and to assess TTGE
band importance. Data were automatically mean centred
and unit variance (UV) scaled by the statistical software.
Each TTGE band was hierarchically classified based on a
software-assigned variable importance (VIP) value. The
variables with VIP value > 1 were chosen as discrimina-
tory. Non-parametric statistical methods. For Shannon-
Weaver index, species-specific PCR, FDA and PLS-DA, a
bilateral Wilcoxon signed rank test was utilized to com-
pare active and inactive CD patients' groups, whilst a
bilateral Mann-Whitney U-test was utilized to compare
active/inactive CD patients with control group. A P value
less than or equal to 0.05 was considered statistically sig-
nificant.
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